|
Sign In to gain access to subscriptions and/or personal tools.
|
Development of Self-assembled Nanoceramic Carrier Construct(s) for Vaccine Delivery
Amit K. Goyal
Department of Pharmaceutical Sciences, Drug Delivery Research Laboratory, Dr Harisingh Gour Vishwavidyalaya, Sagar (MP) 470003, India, Department of Pharmaceutics, ISF College of Pharmacy, Moga (Punjab) 142001, India
Kapil Khatri
Department of Pharmaceutical Sciences, Drug Delivery Research Laboratory, Dr Harisingh Gour Vishwavidyalaya, Sagar (MP) 470003, India
Neeraj Mishra
Department of Pharmaceutical Sciences, Drug Delivery Research Laboratory, Dr Harisingh Gour Vishwavidyalaya, Sagar (MP) 470003, India
Abhinav Mehta
Department of Pharmaceutical Sciences, Drug Delivery Research Laboratory, Dr Harisingh Gour Vishwavidyalaya, Sagar (MP) 470003, India
Bhuvaneshwar Vaidya
Department of Pharmaceutical Sciences, Drug Delivery Research Laboratory, Dr Harisingh Gour Vishwavidyalaya, Sagar (MP) 470003, India, Department of Pharmaceutics, ISF College of Pharmacy, Moga (Punjab) 142001, India
Shailja Tiwari
Department of Pharmaceutical Sciences, Drug Delivery Research Laboratory, Dr Harisingh Gour Vishwavidyalaya, Sagar (MP) 470003, India
Rishi Paliwal
Department of Pharmaceutical Sciences, Drug Delivery Research Laboratory, Dr Harisingh Gour Vishwavidyalaya, Sagar (MP) 470003, India, Department of Pharmaceutics, ISF College of Pharmacy, Moga (Punjab) 142001, India
Shivani Paliwal
Department of Pharmaceutical Sciences, Drug Delivery Research Laboratory, Dr Harisingh Gour Vishwavidyalaya, Sagar (MP) 470003, India, Department of Pharmaceutics, ISF College of Pharmacy, Moga (Punjab) 142001, India
Suresh P. Vyas
Department of Pharmaceutical Sciences, Drug Delivery Research Laboratory, Dr Harisingh Gour Vishwavidyalaya, Sagar (MP) 470003, India, vyas_sp{at}rediffmail.com, spvyas{at}bsnl.in, Department of Pharmaceutics, ISF College of Pharmacy, Moga (Punjab) 142001, India
Hydroxyapatite (HA) has been extensively investigated as scaffolds for tissue engineering, as drug delivery agents, as non-viral gene carriers, as prosthetic coatings, and composites. Recent studies in our laboratory demonstrated the immunoadjuvant properties of HA when administered with malarial merozoite surface protein-119 (MSP-119). HA nanoceramic carrier was prepared by co-precipitation method that comprises of sintering and spray-drying technique. Prepared systems were characterized for crystallinity, size, shape, and antigen loading efficiency. Small size and large surface area of prepared HA demonstrated good adsorption efficiency of immunogens. Prepared nanoceramic formulations also showed slower in vitro antigen release and slower biodegrability behavior, which may lead to a prolonged exposure to antigen-presenting cells and lymphocytes. Furthermore, addition of mannose in nanoceramic formulation may additionally lead to increased stability and immunological reactions. Immunization with MSP-119 in nanoceramic-based adjuvant systems induced a vigorous immunoglobulin G (IgG) response, with higher IgG2a than IgG1 titers. In addition considerable amount of IFN-g and IL-2 was observed in spleen cells of mice immunized with nanoceramic-based vaccines. On the contrary, mice immunized with MSP-119 alone or with alum did not exhibit a significant cytotoxic response. The antibody responses to vaccine co-administered with HA was a mixed Th1/Th2 compared to the Th2-biased response obtained with alum. The prepared HA nanoparticles exhibit physicochemical properties that appear promising to make them a suitable immunoadjuvant to be used as antigen carriers for immunopotentiation.
Key Words: hydroxyapatite nanoparticles malaria vaccines drug delivery.
References
- Storni, T., Kundig, T.M., Senti, G. and Johansen, P. (2005). Immunity in Response to Particulate Antigen-delivery Systems, Adv. Drug Del. Rev., 57: 333-355.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brennan, F.R. and Dougan, G. (2005). Non-clinical Safety Evaluation of Novel Vaccines and Adjuvants: New Products, New Strategies, Vaccine, 23: 3210-3222.
- O'Hagan, D.T., MacKichan, M.L. and Singh, M. (2001). Recent Developments in Adjuvants for Vaccines Against Infectious Diseases, Biomol. Eng., 18: 69-85.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Olton, D., Li, J., Wilson, M.E., Rogers, T., Close, J., Huang, L., Kumta, P.N. and Sfeir, C. (2007). Nanostructured Calcium Phosphates (NanoCaPs) for Non-viral Gene Delivery: Influence of the Synthesis Parameters on Transfection Efficiency, Biomaterials, 28: 1267-1279.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Doonan, S. (2004). Chromatography on Hydroxyapatite, Methods Mol. Biol., 244: 191-194.
- Ueno, Y., Futagawa, H., Takagi, Y., Ueno, A. and Mizushim, Y. (2005). Drug-incorporating Calcium Carbonate Nanoparticles for a New Delivery System, J. Control Rel., 103: 93-98.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wassell, D.T.H., Hall, R.C. and Embery, G. (1995). Adsorption of BSA onto Hydroxyapatite, Biomaterials, 16: 697-702.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kandori, K., Miyagawa, K. and Ishikawa, T. (2004). Adsorption of Gamma Immuno Globulin onto Various Synthetic Calcium Hydroxyapatite Particles, J. Colloid Interf. Sci., 273: 406-413.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Matsumoto, T., Okazaki, M., Inoue, M., Yamaguchi, S., Kusunose, T., Toyonaga, T., Hamada, Y. and Takahashi, J. (2004). Hydroxyapatite Particles as a Controlled Release Carrier of Protein, Biomaterials, 25: 3807-3812.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Luo, Q. and Andrade, J.D. (1998). Cooperative Adsorption of Proteins onto Hydroxyapatite, J. Colloid Interf. Sci., 200: 104-113.[CrossRef][Web of Science]
- Gorbunoff, M.J. (1984). The Interaction of Proteins with Hydroxyapatite, Anal. Biochem., 136: 425-432.
- Paul, W. and Sharma, C.P. (2003). Ceramic Drug Delivery: A Perspective, J. Biomater. Appl., 17: 253-264.[Abstract/Free Full Text]
- Lindblad, E.B. (2004). Aluminium Compounds for use in Vaccines, Immunol. Cell Biol., 82: 497-505.
- Gupta, R.K., Rost, B.E., Relyveld, E. and Siber, G.R. (1995). Adjuvant Properties of Aluminum and Calcium Compounds, In: Powell, M.F. and Newman, M.J. (eds), Vaccine Design: The Subunit and Adjuvant Approach, pp. 229-248, Plenum Press, New York.
- Pham, H.N., Luo, P., Genin, F. and Dash, A.K. (2002). Synthesis and Characterization of Hydroxyapatite-ciprofloxacin Delivery Systems by Precipitation and Spray Drying Technique, AAPS Pharm. Sci. Tech., 3: E1-E7.
- Tas, A.C. (2001). X-ray Diffraction Data for Flux Grown Calcium Hydroxyapatite Whiskers, Powder Diffr., 16: 102-106.[CrossRef]
- Mizushima, Y., Ikoma, T., Tanaka, J., Hoshi, K., Ishihara, T., Ogawa, Y. and Ueno, A. (2006). Injectable Porous Hydroxyapatite Microparticles as a New Carrier for Protein and Lipophilic Drugs, J. Control Rel., 110: 260-265.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Dias, A.G., Lopes, M.A. and Santos, J.D. (2006). In Vivo Performance of Biodegradable Calcium Phosphate Glass Ceramics using the Rabbit Model: Histological and Sem Observation, J. Biomater. Appl., 20: 253-266.[Abstract/Free Full Text]
- Sachdeva, S., Ahmad, G., Malhotra, P., Mukherjee, P. and Chauhan, V.S. (2004). Comparison of Immunogenicities of Recombinant Plasmodium Vivax Merozoite Surface Protein 119 and 42 kilodalton Fragments Expressed in Escherichia coli, Infect. Immun., 70(10): 5775-5785.
- Saifuddin, M., Hart, M.L., Gewurz, H., Zhang, Y. and Spear, G.T. (2000). Interaction of Mannose-binding Lectin with Primary Isolates of Human Immunodeficiency Virus Type 1, J. Gen. Virol., 81: 949-955.[Abstract/Free Full Text]
- Hegde, V.L. and Venkatesh, Y.P. (2007). Generation of Antibodies Specific to D-mannitol, a Unique Haptenic Allergen, using Reductively Aminated D-mannose-bovine Serum Albumin Conjugate as the Immunogen Immunobiol, 212: 119-128.
- Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y., Pulendran, B. and Palucka, K. (2000). Immunobiology of Dendritic Cells, Annu. Rev. Immunol., 8: 767-811.
This version was published on July
1, 2009
Journal of Biomaterials Applications, Vol. 24, No. 1,
65-84 (2009)
DOI: 10.1177/0885328209104018

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|